Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1951 1
1952 1
1953 7
1954 4
1955 1
1956 1
1957 3
1961 2
1962 5
1963 7
1964 6
1965 3
1966 9
1967 5
1968 4
1969 2
1970 6
1971 12
1972 4
1973 11
1974 10
1975 7
1976 5
1977 5
1978 5
1979 10
1980 10
1981 16
1982 13
1983 7
1984 11
1985 13
1986 14
1987 5
1988 12
1989 16
1990 12
1991 6
1992 11
1993 2
1994 2
1995 1
1996 5
1997 3
1998 3
1999 1
2000 7
2001 6
2002 6
2003 6
2004 7
2005 10
2006 11
2007 10
2008 6
2009 2
2010 7
2011 5
2012 7
2013 6
2014 8
2015 13
2016 9
2017 17
2018 10
2019 11
2020 15
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

463 results
Results by year
Filters applied: . Clear all
Page 1
Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial.
Ishigami H, Fujiwara Y, Fukushima R, Nashimoto A, Yabusaki H, Imano M, Imamoto H, Kodera Y, Uenosono Y, Amagai K, Kadowaki S, Miwa H, Yamaguchi H, Yamaguchi T, Miyaji T, Kitayama J. Ishigami H, et al. Among authors: miyaji t. J Clin Oncol. 2018 Jul 1;36(19):1922-1929. doi: 10.1200/JCO.2018.77.8613. Epub 2018 May 10. J Clin Oncol. 2018. PMID: 29746229 Clinical Trial.
Additive Duloxetine for Cancer-Related Neuropathic Pain Nonresponsive or Intolerant to Opioid-Pregabalin Therapy: A Randomized Controlled Trial (JORTC-PAL08).
Matsuoka H, Iwase S, Miyaji T, Kawaguchi T, Ariyoshi K, Oyamada S, Satomi E, Ishiki H, Hasuo H, Sakuma H, Tokoro A, Shinomiya T, Otani H, Ohtake Y, Tsukuura H, Matsumoto Y, Hasegawa Y, Kataoka Y, Otsuka M, Sakai K, Matsuda Y, Morita T, Koyama A, Yamaguchi T. Matsuoka H, et al. Among authors: miyaji t. J Pain Symptom Manage. 2019 Oct;58(4):645-653. doi: 10.1016/j.jpainsymman.2019.06.020. Epub 2019 Jun 26. J Pain Symptom Manage. 2019. PMID: 31254640 Free article. Clinical Trial.
Predictors of duloxetine response in patients with neuropathic cancer pain: a secondary analysis of a randomized controlled trial-JORTC-PAL08 (DIRECT) study.
Matsuoka H, Iwase S, Miyaji T, Kawaguchi T, Ariyoshi K, Oyamada S, Satomi E, Ishiki H, Hasuo H, Sakuma H, Tokoro A, Matsuda Y, Tahara K, Otani H, Ohtake Y, Tsukuura H, Matsumoto Y, Hasegawa Y, Kataoka Y, Otsuka M, Sakai K, Nakura M, Morita T, Yamaguchi T, Koyama A. Matsuoka H, et al. Among authors: miyaji t. Support Care Cancer. 2020 Jun;28(6):2931-2939. doi: 10.1007/s00520-019-05138-9. Epub 2019 Nov 25. Support Care Cancer. 2020. PMID: 31761974 Clinical Trial.
Early Predictors of Objective Response in Patients with Hepatocellular Carcinoma Undergoing Lenvatinib Treatment.
Saeki I, Yamasaki T, Yamashita S, Hanazono T, Urata Y, Furutani T, Yokoyama Y, Oishi T, Maeda M, Kimura T, Kotoh Y, Sasaki R, Miyaji T, Oono T, Aibe Y, Hisanaga T, Iwamoto T, Matsumoto T, Hidaka I, Ishikawa T, Takami T, Sakaida I. Saeki I, et al. Among authors: miyaji t. Cancers (Basel). 2020 Mar 25;12(4):779. doi: 10.3390/cancers12040779. Cancers (Basel). 2020. PMID: 32218295 Free PMC article.
[Patient Reported Outcome(PRO)in Oncology].
Yamaguchi T, Kawaguchi T, Miyaji T. Yamaguchi T, et al. Among authors: miyaji t. Gan To Kagaku Ryoho. 2019 Sep;46(9):1345-1356. Gan To Kagaku Ryoho. 2019. PMID: 31530769 Japanese.
Smartphone problem-solving and behavioural activation therapy to reduce fear of recurrence among patients with breast cancer (SMartphone Intervention to LEssen fear of cancer recurrence: SMILE project): protocol for a randomised controlled trial.
Akechi T, Yamaguchi T, Uchida M, Imai F, Momino K, Katsuki F, Sakurai N, Miyaji T, Horikoshi M, Furukawa TA, Iwata H, Uchitomi Y. Akechi T, et al. Among authors: miyaji t. BMJ Open. 2018 Nov 8;8(11):e024794. doi: 10.1136/bmjopen-2018-024794. BMJ Open. 2018. PMID: 30413519 Free PMC article. Clinical Trial.
Cell surface CD63 increased by up-regulated polylactosamine modification sensitizes human melanoma cells to the BRAF inhibitor PLX4032.
Kudo K, Yoneda A, Sakiyama D, Kojima K, Miyaji T, Yamazaki M, Yaita S, Hyodo T, Satow R, Fukami K. Kudo K, et al. Among authors: miyaji t. FASEB J. 2019 Mar;33(3):3851-3869. doi: 10.1096/fj.201800664RR. Epub 2018 Dec 3. FASEB J. 2019. PMID: 30508500
Genome editing in plants using CRISPR type I-D nuclease.
Osakabe K, Wada N, Miyaji T, Murakami E, Marui K, Ueta R, Hashimoto R, Abe-Hara C, Kong B, Yano K, Osakabe Y. Osakabe K, et al. Among authors: miyaji t. Commun Biol. 2020 Nov 6;3(1):648. doi: 10.1038/s42003-020-01366-6. Commun Biol. 2020. PMID: 33159140 Free PMC article.
Divalent cation transport by vesicular nucleotide transporter.
Miyaji T, Sawada K, Omote H, Moriyama Y. Miyaji T, et al. J Biol Chem. 2011 Dec 16;286(50):42881-7. doi: 10.1074/jbc.M111.277269. Epub 2011 Nov 3. J Biol Chem. 2011. PMID: 22052906 Free PMC article.
Node-Localized Transporters of Phosphorus Essential for Seed Development in Rice.
Che J, Yamaji N, Miyaji T, Mitani-Ueno N, Kato Y, Shen RF, Ma JF. Che J, et al. Among authors: miyaji t. Plant Cell Physiol. 2020 Aug 1;61(8):1387-1398. doi: 10.1093/pcp/pcaa074. Plant Cell Physiol. 2020. PMID: 32484878
463 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page